Roth Capital Forecasts Lower Earnings for Verona Pharma
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Roth Capital dropped their Q1 2026 EPS estimates for shares of Verona Pharma in a note issued to investors on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now anticipates that the company will post earnings per share of $0.68 for the quarter, down […]
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Roth Capital dropped their Q1 2026 EPS estimates for shares of Verona Pharma in a note issued to investors on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now anticipates that the company will post earnings per share of $0.68 for the quarter, down […]
